Indivior Pharmaceuticals Inc. Common Stock vs TD SYNNEX Corporation Common Stock — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B), while TD SYNNEX Corporation Common Stock trades at $262 (market cap $22.02B). The key difference: TD SYNNEX Corporation Common Stock is far larger — about 5.3× Indivior Pharmaceuticals Inc. Common Stock's market cap, and TD SYNNEX Corporation Common Stock pays a 0.7% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and TD SYNNEX Corporation Common Stock for 0 Days on average.
| INDV | SNX | |
|---|---|---|
Market Cap | $4.18B | $22.02B |
Volume | 1,819,746 | 614,208 |
Sector | Health | Technology |
52-Week High | $41.83 | $290.14 |
52-Week Low | $24.09 | $142.42 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.47B | $26.79B |
Dividend Yield | — | 0.7% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →TD SYNNEX Corporation is a global IT distributor and solutions aggregator that distributes endpoint devices and data-center technologies from technology vendors to resellers and customers worldwide.
Read more on SNX →